Table 3 miRNA expression and prognostic factors of ccRCC

Low (n = 18)

60.12(104.18)

0.51(1.34)

17.89(34.38)

22.01(37.5)

2.10(4.1)

19.25(28.23)

3.94(7.35)

Intermediate (n = 29)

59.99(159.22)

5.62(25.37)

22.18 (49.15)

13.07(31.1)

0.96(2.9)

10.90(28.49)

2.72(2.89)

High n = 9

48.64(85.19)

0.77(1.75)

44.44(75.01)

65.13(159.)

0.37(0.3)

7.05(9.72)

5.30(2.91)

P

0.65^b

0.63^b

0.50^b

0.17^b

0.29^b

0.57^b

0.47^b

Size ≥7 cm (n = 30)

61.13(91.26)

5.69(26.31)

19.77(39.93)

22.79(42.3)

1.57(3.6)

13.80(24.88)

3.48(6.21)

Size <7 cm (n = 26)

55.80(166.90)

0.90(2.77)

27.68(56.40)

23.59(84.3)

1.02(2.1)

12.62(28.97)

3.29(2.90)

P

0.88^a

0.36^a

0.57^a

0.96^a

0.49^a

0.88^a

0.12^a

MVI absent (n = 44)

63.00(145.83)

3.90(20.87)

15.77(34.2)

17.73(35.1)

1.55(3.2)

15.24(29.69)

3.19(5.13)

MVI present (n = 12)

43.28(73.27)

0.88(1.80)

51.97(76.99)

43.48(127.)

0.36(0.3)

5.37(7.45)

4.30(3.50)

P

0.65^a

0.63^a

0.05^a

0.72^a

0,43^a

0.33^a

0.54^a

Fuhrman’s Grade I e II (n = 32)

39.95(87.23)

0.49(1.32)

23.61(45.13)

17.40(31.4)

1.92(3.7)

19.08(34.41)

3.63(6.04)

Fuhrman’s Grade III e IV (n = 24)

79.35(169.23)

6.35(26.88)

23.28(52.73)

29.41(88.9)

0.55(1.2)

5.70(7.80)

3.11(3.06)

p

0.28^a

0.33^a

0.98^a

0.51^a

0.03 ^a

0.10^a

0,71^a

pT1–2 (n = 26)

50.88(82.18)

6.36(27.40)

22.79(42.04)

23.35(43.8)

1.19(2.7)

14.85(25.19)

3.86(6.32)

pT3–4 (n = 30)

65.37(166.50)

0.69(2.59)

24.12(53.93)

23.01(81.1)

1.41(3.1)

11.84(28.52)

2.96(3.03)

P

0.69^a

0.28^a

0.92^a

0.98^a

0.78^a

0.71^a

0.51^a

Metastasis Absent (n = 48)

49.76(84.62)

3.46(19.85)

19.01(39.85)

25.78(69.88)

1.17(2.54)

12.23(26.81)

3.61(418.33)

Metastasis Present (n = 8)

107.88(286.69)

1.89(4.94)

48.92(81.75)

6.41(6.35)

2.20(5.18)

18.95(28.74)

2.24(3.24)

p

0.25^a

0.83^a

0.12^a

0.47^a

0.39^a

0.57^a

0.46^a